Offer - Urjas Oil for just ₹ 1
Exelon 3 Capsule (14) is a prescription drug, available for use as Capsule. Primarily, it is used for the treatment of Alzheimer's Disease, Parkinson's Disease. Secondary and off-label uses of Exelon 3 Capsule (14) have also been mentioned below.
The correct dosage of Exelon 3 Capsule (14) depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Exelon 3 Capsule (14) are Fainting, Indigestion. Besides the aforementioned side effects, there are other adverse effects of Exelon 3 Capsule (14) as well, which are listed below. Usually, these side effects of Exelon 3 Capsule (14) go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Exelon 3 Capsule (14)'s effect is Safe during pregnancy and Mild for lactating mothers. Further, the section on Exelon 3 Capsule (14) related warnings talks about Exelon 3 Capsule (14)'s effects on the liver, heart and kidney.
Exelon 3 Capsule (14) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Exelon 3 Capsule (14) in conditions like Kidney Disease, Asthma, COPD (Chronic Obstructive Pulmonary Disease). The section on Exelon 3 Capsule (14) contraindications lists all such conditions.
Additionally, Exelon 3 Capsule (14) may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Exelon 3 Capsule (14) is not safe while driving, and is is not addictive in nature.
Exelon 3 Capsule (14) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Exelon 3 Capsule (14) safe for pregnant women?
Exelon is safe to take during pregnancy.
Is the use of Exelon 3 Capsule (14) safe during breastfeeding?
Exelon may have very limited harmful effects for breastfeeding women.
What is the effect of Exelon 3 Capsule (14) on the Kidneys?
Exelon rarely affects the kidneys.
What is the effect of Exelon 3 Capsule (14) on the Liver?
Exelon may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Exelon 3 Capsule (14) on the Heart?
You can take Exelon without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Exelon 3 Capsule (14) unless your doctor advises you to do so -
Is this Exelon 3 Capsule (14) habit forming or addictive?
No, you will not get addicted to Exelon 3 Capsule (14).
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Exelon 3 Capsule (14). So it is best to avoid driving.
Is it safe?
Yes, but take Exelon 3 Capsule (14) only as per medical advice.
Is it able to treat mental disorders?
Exelon 3 Capsule (14) has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Exelon 3 Capsule (14)
Taking Exelon 3 Capsule (14) with food does not cause any problems.
Interaction between Alcohol and Exelon 3 Capsule (14)
Consumption of alcohol and Exelon 3 Capsule (14) together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Exelon® (rivastigmine tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 108
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1110-1112
